Advertisement

Index by author

September 01, 1982; Volume 22,Issue 2

A

  1. Abell, C W

    1. A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A.
      R M Denney, N T Patel, R R Fritz and C W Abell
      Molecular Pharmacology September 1982, 22 (2) 500-508;

  2. Adams, S M

    1. Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides.
      S M Adams and L S Kaminsky
      Molecular Pharmacology September 1982, 22 (2) 459-464;

  3. Aguilar, J S

    1. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
      J S Aguilar, P J Salas and E De Robertis
      Molecular Pharmacology September 1982, 22 (2) 304-309;

  4. Aktories, K

    1. Guanine nucleotides and monovalent cations increase agonist affinity of prostaglandin E2 receptors in hamster adipocytes.
      R Grandt, K Aktories and K H Jakobs
      Molecular Pharmacology September 1982, 22 (2) 320-326;

  5. Andersson, B

    1. Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products.
      B Andersson, M Nordenskjöld, A Rahimtula and P Moldéus
      Molecular Pharmacology September 1982, 22 (2) 479-485;

B

  1. Bader, H

    1. Effects of microtubular inhibitors on plasma membrane calmodulin-dependent Ca2+-transport ATPase.
      K Gietzen, A Wüthrich and H Bader
      Molecular Pharmacology September 1982, 22 (2) 413-420;

  2. Baguley, B C

    1. Comparison of the in vivo and in vitro antileukemic activity of monosubstituted derivatives of 4'-(9-acridinylamino)methanesulfon-m-anisidide.
      B C Baguley and B F Cain
      Molecular Pharmacology September 1982, 22 (2) 486-492;

  3. Barsuhn, C

    1. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
      B V Cheney, R A Lahti, C Barsuhn and D D Gay
      Molecular Pharmacology September 1982, 22 (2) 349-359;

  4. Baxter, D

    1. Enzyme regulatory site-directed drugs. MOdulation of thymidine triphosphate inhibition of thymidine kinase by 5'-amino-5'-deoxythymidine.
      P H Fischer and D Baxter
      Molecular Pharmacology September 1982, 22 (2) 231-234;

  5. Boyle, M R

    1. Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1.
      R J Hughes, M R Boyle, R D Brown, P Taylor and P A Insel
      Molecular Pharmacology September 1982, 22 (2) 258-266;

  6. Brown, R D

    1. Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1.
      R J Hughes, M R Boyle, R D Brown, P Taylor and P A Insel
      Molecular Pharmacology September 1982, 22 (2) 258-266;

C

  1. Cain, B F

    1. Comparison of the in vivo and in vitro antileukemic activity of monosubstituted derivatives of 4'-(9-acridinylamino)methanesulfon-m-anisidide.
      B C Baguley and B F Cain
      Molecular Pharmacology September 1982, 22 (2) 486-492;

  2. Camus, J

    1. Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment.
      P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus and J Christophe
      Molecular Pharmacology September 1982, 22 (2) 342-348;

  3. Caron, M G

    1. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
      A De Lean, B F Kilpatrick and M G Caron
      Molecular Pharmacology September 1982, 22 (2) 290-297;
    2. Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides.
      B F Kilpatrick, A De Lean and M G Caron
      Molecular Pharmacology September 1982, 22 (2) 298-303;

  4. Carter, T H

    1. Effects of adenine nucleosides on RNA synthesis in adenovirus-infected cells. 9-beta-D-Arabinofuranosyladenine as a selective inhibitor of RNA polyadenylation.
      K M Rose, T B Leonard and T H Carter
      Molecular Pharmacology September 1982, 22 (2) 517-523;

  5. Cech, S Y

    1. Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation.
      S Y Cech and M E Maguire
      Molecular Pharmacology September 1982, 22 (2) 267-273;

  6. Chatelain, P

    1. Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment.
      P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus and J Christophe
      Molecular Pharmacology September 1982, 22 (2) 342-348;

  7. Cheney, B V

    1. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
      B V Cheney, R A Lahti, C Barsuhn and D D Gay
      Molecular Pharmacology September 1982, 22 (2) 349-359;

  8. Cho, A K

    1. N-oxidation of phentermine to N-hydroxyphentermine by a reconstituted cytochrome P-450 oxidase system from rabbit liver.
      J D Duncan and A K Cho
      Molecular Pharmacology September 1982, 22 (2) 235-238;
    2. The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.
      A K Cho, M S Maynard, R M Matsumoto, B Lindeke, U Paulsen and G T Miwa
      Molecular Pharmacology September 1982, 22 (2) 465-470;

  9. Christophe, J

    1. Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment.
      P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus and J Christophe
      Molecular Pharmacology September 1982, 22 (2) 342-348;

  10. Conway, J G

    1. Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, S Ji and R G Thurman
      Molecular Pharmacology September 1982, 22 (2) 509-516;

  11. Covey, D F

    1. Comparison of epileptogenic properties of unsubstituted and beta-alkyl-substituted gamma-butyrolactones.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 431-437;
    2. Anticonvulsant properties of alpha, gamma, and alpha, gamma-substituted gamma-butyrolactones.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 438-443;
    3. Structure-activity relationships of alkyl-substituted gamma-butyrolactones and succinimides.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 444-450;

D

  1. De Lean, A

    1. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
      A De Lean, B F Kilpatrick and M G Caron
      Molecular Pharmacology September 1982, 22 (2) 290-297;
    2. Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides.
      B F Kilpatrick, A De Lean and M G Caron
      Molecular Pharmacology September 1982, 22 (2) 298-303;

  2. De Neef, P

    1. Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment.
      P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus and J Christophe
      Molecular Pharmacology September 1982, 22 (2) 342-348;

  3. Denney, R M

    1. A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A.
      R M Denney, N T Patel, R R Fritz and C W Abell
      Molecular Pharmacology September 1982, 22 (2) 500-508;

  4. De Robertis, E

    1. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
      J S Aguilar, P J Salas and E De Robertis
      Molecular Pharmacology September 1982, 22 (2) 304-309;

  5. Duncan, J D

    1. N-oxidation of phentermine to N-hydroxyphentermine by a reconstituted cytochrome P-450 oxidase system from rabbit liver.
      J D Duncan and A K Cho
      Molecular Pharmacology September 1982, 22 (2) 235-238;

F

  1. Ferrendelli, J A

    1. Comparison of epileptogenic properties of unsubstituted and beta-alkyl-substituted gamma-butyrolactones.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 431-437;
    2. Anticonvulsant properties of alpha, gamma, and alpha, gamma-substituted gamma-butyrolactones.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 438-443;
    3. Structure-activity relationships of alkyl-substituted gamma-butyrolactones and succinimides.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 444-450;

  2. Fischer, P H

    1. Enzyme regulatory site-directed drugs. MOdulation of thymidine triphosphate inhibition of thymidine kinase by 5'-amino-5'-deoxythymidine.
      P H Fischer and D Baxter
      Molecular Pharmacology September 1982, 22 (2) 231-234;

  3. Fritz, R R

    1. A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A.
      R M Denney, N T Patel, R R Fritz and C W Abell
      Molecular Pharmacology September 1982, 22 (2) 500-508;

G

  1. Gay, D D

    1. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
      B V Cheney, R A Lahti, C Barsuhn and D D Gay
      Molecular Pharmacology September 1982, 22 (2) 349-359;

  2. Gewirtz, D A

    1. Catecholamine-induced release of the folic acid analogue, methotrexate, from rat hepatocytes in suspension. An alpha-adrenergic phenomenon.
      D A Gewirtz, J K Randolph and I D Goldman
      Molecular Pharmacology September 1982, 22 (2) 493-499;

  3. Gietzen, K

    1. Effects of microtubular inhibitors on plasma membrane calmodulin-dependent Ca2+-transport ATPase.
      K Gietzen, A Wüthrich and H Bader
      Molecular Pharmacology September 1982, 22 (2) 413-420;

  4. Goldman, I D

    1. Catecholamine-induced release of the folic acid analogue, methotrexate, from rat hepatocytes in suspension. An alpha-adrenergic phenomenon.
      D A Gewirtz, J K Randolph and I D Goldman
      Molecular Pharmacology September 1982, 22 (2) 493-499;

  5. Goren, H J

    1. Oxytocin action. Mechanisms for insulin-like activity in isolated rat adipocytes.
      K Hanif, H J Goren, M D Hollenberg and K Lederis
      Molecular Pharmacology September 1982, 22 (2) 381-388;

  6. Gorissen, H

    1. Characterization of solubilized serotonin (S2) receptors in rat brain.
      B Ilien, H Gorissen and P M Laduron
      Molecular Pharmacology September 1982, 22 (2) 243-249;

  7. Grandt, R

    1. Guanine nucleotides and monovalent cations increase agonist affinity of prostaglandin E2 receptors in hamster adipocytes.
      R Grandt, K Aktories and K H Jakobs
      Molecular Pharmacology September 1982, 22 (2) 320-326;

H

  1. Hanif, K

    1. Oxytocin action. Mechanisms for insulin-like activity in isolated rat adipocytes.
      K Hanif, H J Goren, M D Hollenberg and K Lederis
      Molecular Pharmacology September 1982, 22 (2) 381-388;

  2. Harden, T K

    1. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase.
      R B Meeker and T K Harden
      Molecular Pharmacology September 1982, 22 (2) 310-319;

  3. Harrelson, W G

    1. Microsomal reduction of gentian violet. Evidence for cytochrome P-450-catalyzed free radical formation.
      W G Harrelson and R P Mason
      Molecular Pharmacology September 1982, 22 (2) 239-242;

  4. Hidaka, H

    1. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 403-407;
    2. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura, T Yamakado and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 408-412;

  5. Hirsch, J D

    1. Thermodynamic changes associated with benzodiazepine and alkyl beta-carboline-3-carboxylate binding to rat brain homogenates.
      R L Kochman and J D Hirsch
      Molecular Pharmacology September 1982, 22 (2) 335-341;

  6. Hollenberg, M D

    1. Oxytocin action. Mechanisms for insulin-like activity in isolated rat adipocytes.
      K Hanif, H J Goren, M D Hollenberg and K Lederis
      Molecular Pharmacology September 1982, 22 (2) 381-388;

  7. Hughes, R J

    1. Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1.
      R J Hughes, M R Boyle, R D Brown, P Taylor and P A Insel
      Molecular Pharmacology September 1982, 22 (2) 258-266;

I

  1. Ilien, B

    1. Characterization of solubilized serotonin (S2) receptors in rat brain.
      B Ilien, H Gorissen and P M Laduron
      Molecular Pharmacology September 1982, 22 (2) 243-249;

  2. Insel, P A

    1. Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1.
      R J Hughes, M R Boyle, R D Brown, P Taylor and P A Insel
      Molecular Pharmacology September 1982, 22 (2) 258-266;

J

  1. Jakobs, K H

    1. Guanine nucleotides and monovalent cations increase agonist affinity of prostaglandin E2 receptors in hamster adipocytes.
      R Grandt, K Aktories and K H Jakobs
      Molecular Pharmacology September 1982, 22 (2) 320-326;

  2. Jefcoate, C R

    1. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes.
      G M Keller, C R Turner and C R Jefcoate
      Molecular Pharmacology September 1982, 22 (2) 451-458;

  3. Ji, S

    1. Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, S Ji and R G Thurman
      Molecular Pharmacology September 1982, 22 (2) 509-516;

K

  1. Kaminsky, L S

    1. Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides.
      S M Adams and L S Kaminsky
      Molecular Pharmacology September 1982, 22 (2) 459-464;

  2. Kauffman, F C

    1. Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, S Ji and R G Thurman
      Molecular Pharmacology September 1982, 22 (2) 509-516;

  3. Keller, G M

    1. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes.
      G M Keller, C R Turner and C R Jefcoate
      Molecular Pharmacology September 1982, 22 (2) 451-458;

  4. Kenimer, J G

    1. The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.
      R McGee and J G Kenimer
      Molecular Pharmacology September 1982, 22 (2) 360-368;

  5. Kharasch, E D

    1. Inhibition of microsomal oxidative drug metabolism by 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate, a new antineoplastic agent.
      E D Kharasch and R F Novak
      Molecular Pharmacology September 1982, 22 (2) 471-478;

  6. Kilpatrick, B F

    1. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
      A De Lean, B F Kilpatrick and M G Caron
      Molecular Pharmacology September 1982, 22 (2) 290-297;
    2. Dopamine receptor of the porcine anterior pituitary gland. Effects of N-ethylmaleimide and heat on ligand binding mimic the effects of guanine nucleotides.
      B F Kilpatrick, A De Lean and M G Caron
      Molecular Pharmacology September 1982, 22 (2) 298-303;

  7. Klunk, W E

    1. Comparison of epileptogenic properties of unsubstituted and beta-alkyl-substituted gamma-butyrolactones.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 431-437;
    2. Anticonvulsant properties of alpha, gamma, and alpha, gamma-substituted gamma-butyrolactones.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 438-443;
    3. Structure-activity relationships of alkyl-substituted gamma-butyrolactones and succinimides.
      W E Klunk, D F Covey and J A Ferrendelli
      Molecular Pharmacology September 1982, 22 (2) 444-450;

  8. Kochman, R L

    1. Thermodynamic changes associated with benzodiazepine and alkyl beta-carboline-3-carboxylate binding to rat brain homogenates.
      R L Kochman and J D Hirsch
      Molecular Pharmacology September 1982, 22 (2) 335-341;

L

  1. Laduron, P M

    1. Characterization of solubilized serotonin (S2) receptors in rat brain.
      B Ilien, H Gorissen and P M Laduron
      Molecular Pharmacology September 1982, 22 (2) 243-249;

  2. Lahti, R A

    1. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
      B V Cheney, R A Lahti, C Barsuhn and D D Gay
      Molecular Pharmacology September 1982, 22 (2) 349-359;

  3. Lederis, K

    1. Oxytocin action. Mechanisms for insulin-like activity in isolated rat adipocytes.
      K Hanif, H J Goren, M D Hollenberg and K Lederis
      Molecular Pharmacology September 1982, 22 (2) 381-388;

  4. Leonard, T B

    1. Effects of adenine nucleosides on RNA synthesis in adenovirus-infected cells. 9-beta-D-Arabinofuranosyladenine as a selective inhibitor of RNA polyadenylation.
      K M Rose, T B Leonard and T H Carter
      Molecular Pharmacology September 1982, 22 (2) 517-523;

  5. Lindeke, B

    1. The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.
      A K Cho, M S Maynard, R M Matsumoto, B Lindeke, U Paulsen and G T Miwa
      Molecular Pharmacology September 1982, 22 (2) 465-470;

M

  1. Maguire, M E

    1. Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation.
      S Y Cech and M E Maguire
      Molecular Pharmacology September 1982, 22 (2) 267-273;
    2. Magnesium regulation of the beta-receptor-adenylate cyclase complex. II. Sc3+ as a Mg2 antagonist.
      M E Maguire
      Molecular Pharmacology September 1982, 22 (2) 274-280;

  2. Markstein, R

    1. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
      M P Seiler and R Markstein
      Molecular Pharmacology September 1982, 22 (2) 281-289;

  3. Mason, R P

    1. Microsomal reduction of gentian violet. Evidence for cytochrome P-450-catalyzed free radical formation.
      W G Harrelson and R P Mason
      Molecular Pharmacology September 1982, 22 (2) 239-242;

  4. Matsumoto, R M

    1. The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.
      A K Cho, M S Maynard, R M Matsumoto, B Lindeke, U Paulsen and G T Miwa
      Molecular Pharmacology September 1982, 22 (2) 465-470;

  5. Maynard, M S

    1. The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.
      A K Cho, M S Maynard, R M Matsumoto, B Lindeke, U Paulsen and G T Miwa
      Molecular Pharmacology September 1982, 22 (2) 465-470;

  6. McGee, R

    1. The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.
      R McGee and J G Kenimer
      Molecular Pharmacology September 1982, 22 (2) 360-368;

  7. Meeker, R B

    1. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase.
      R B Meeker and T K Harden
      Molecular Pharmacology September 1982, 22 (2) 310-319;

  8. Miwa, G T

    1. The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.
      A K Cho, M S Maynard, R M Matsumoto, B Lindeke, U Paulsen and G T Miwa
      Molecular Pharmacology September 1982, 22 (2) 465-470;

  9. Moldéus, P

    1. Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products.
      B Andersson, M Nordenskjöld, A Rahimtula and P Moldéus
      Molecular Pharmacology September 1982, 22 (2) 479-485;

  10. Murphy, K M

    1. Heterogeneity of adenosine A1 receptor binding in brain tissue.
      K M Murphy and S H Snyder
      Molecular Pharmacology September 1982, 22 (2) 250-257;

N

  1. Nadler, H

    1. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain.
      R Nehmad, H Nadler and R Simantov
      Molecular Pharmacology September 1982, 22 (2) 389-394;

  2. Nehmad, R

    1. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain.
      R Nehmad, H Nadler and R Simantov
      Molecular Pharmacology September 1982, 22 (2) 389-394;

  3. Nordenskjöld, M

    1. Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products.
      B Andersson, M Nordenskjöld, A Rahimtula and P Moldéus
      Molecular Pharmacology September 1982, 22 (2) 479-485;

  4. Norman, J A

    1. Calmodulin inhibitors activate glycogen phosphorylase B to A conversion in C6 glioma cells.
      J A Norman and M Staehelin
      Molecular Pharmacology September 1982, 22 (2) 395-402;

  5. Novak, R F

    1. Inhibition of microsomal oxidative drug metabolism by 1,4-bis (2-[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate, a new antineoplastic agent.
      E D Kharasch and R F Novak
      Molecular Pharmacology September 1982, 22 (2) 471-478;

O

  1. Ohmura, T

    1. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 403-407;
    2. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura, T Yamakado and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 408-412;

P

  1. Patel, N T

    1. A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A.
      R M Denney, N T Patel, R R Fritz and C W Abell
      Molecular Pharmacology September 1982, 22 (2) 500-508;

  2. Paulsen, U

    1. The opposing effects of N-hydroxyamphetamine and N-hydroxyphentermine on the H2O2 generated by hepatic cytochrome P-450.
      A K Cho, M S Maynard, R M Matsumoto, B Lindeke, U Paulsen and G T Miwa
      Molecular Pharmacology September 1982, 22 (2) 465-470;

  3. Pennefather, P

    1. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
      P Pennefather and D M Quastel
      Molecular Pharmacology September 1982, 22 (2) 369-380;

Q

  1. Quastel, D M

    1. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
      P Pennefather and D M Quastel
      Molecular Pharmacology September 1982, 22 (2) 369-380;

R

  1. Rahimtula, A

    1. Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products.
      B Andersson, M Nordenskjöld, A Rahimtula and P Moldéus
      Molecular Pharmacology September 1982, 22 (2) 479-485;

  2. Randolph, J K

    1. Catecholamine-induced release of the folic acid analogue, methotrexate, from rat hepatocytes in suspension. An alpha-adrenergic phenomenon.
      D A Gewirtz, J K Randolph and I D Goldman
      Molecular Pharmacology September 1982, 22 (2) 493-499;

  3. Robberecht, P

    1. Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment.
      P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus and J Christophe
      Molecular Pharmacology September 1982, 22 (2) 342-348;

  4. Rose, K M

    1. Effects of adenine nucleosides on RNA synthesis in adenovirus-infected cells. 9-beta-D-Arabinofuranosyladenine as a selective inhibitor of RNA polyadenylation.
      K M Rose, T B Leonard and T H Carter
      Molecular Pharmacology September 1982, 22 (2) 517-523;

S

  1. Saederup, E

    1. gamma-aminobutyric acid receptors modulate cation binding sites coupled to independent benzodiazepine, picrotoxin, and anion binding sites.
      R F Squires and E Saederup
      Molecular Pharmacology September 1982, 22 (2) 327-334;

  2. Salas, P J

    1. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
      J S Aguilar, P J Salas and E De Robertis
      Molecular Pharmacology September 1982, 22 (2) 304-309;

  3. Seiler, M P

    1. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
      M P Seiler and R Markstein
      Molecular Pharmacology September 1982, 22 (2) 281-289;

  4. Simantov, R

    1. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain.
      R Nehmad, H Nadler and R Simantov
      Molecular Pharmacology September 1982, 22 (2) 389-394;

  5. Snyder, S H

    1. Heterogeneity of adenosine A1 receptor binding in brain tissue.
      K M Murphy and S H Snyder
      Molecular Pharmacology September 1982, 22 (2) 250-257;

  6. Squires, R F

    1. gamma-aminobutyric acid receptors modulate cation binding sites coupled to independent benzodiazepine, picrotoxin, and anion binding sites.
      R F Squires and E Saederup
      Molecular Pharmacology September 1982, 22 (2) 327-334;

  7. Staehelin, M

    1. Calmodulin inhibitors activate glycogen phosphorylase B to A conversion in C6 glioma cells.
      J A Norman and M Staehelin
      Molecular Pharmacology September 1982, 22 (2) 395-402;

T

  1. Tanaka, T

    1. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 403-407;
    2. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura, T Yamakado and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 408-412;

  2. Tank, A W

    1. Induction of tyrosine hydroxylase by glucocorticoids in mouse neuroblastoma cells. Enhancement of the induction by cyclic AMP.
      A W Tank and N Weiner
      Molecular Pharmacology September 1982, 22 (2) 421-430;

  3. Taylor, P

    1. Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1.
      R J Hughes, M R Boyle, R D Brown, P Taylor and P A Insel
      Molecular Pharmacology September 1982, 22 (2) 258-266;

  4. Thurman, R G

    1. Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.
      J G Conway, F C Kauffman, S Ji and R G Thurman
      Molecular Pharmacology September 1982, 22 (2) 509-516;

  5. Turner, C R

    1. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes.
      G M Keller, C R Turner and C R Jefcoate
      Molecular Pharmacology September 1982, 22 (2) 451-458;

W

  1. Waelbroeck, M

    1. Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment.
      P Chatelain, P Robberecht, M Waelbroeck, P De Neef, J Camus and J Christophe
      Molecular Pharmacology September 1982, 22 (2) 342-348;

  2. Weiner, N

    1. Induction of tyrosine hydroxylase by glucocorticoids in mouse neuroblastoma cells. Enhancement of the induction by cyclic AMP.
      A W Tank and N Weiner
      Molecular Pharmacology September 1982, 22 (2) 421-430;

  3. Wüthrich, A

    1. Effects of microtubular inhibitors on plasma membrane calmodulin-dependent Ca2+-transport ATPase.
      K Gietzen, A Wüthrich and H Bader
      Molecular Pharmacology September 1982, 22 (2) 413-420;

Y

  1. Yamakado, T

    1. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
      T Tanaka, T Ohmura, T Yamakado and H Hidaka
      Molecular Pharmacology September 1982, 22 (2) 408-412;
Back to top

In this issue

Advertisement